A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults

NCT00938639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Caused by the Novel Influenza A (H1N1) Virus

Interventions

BIOLOGICAL: CSL425
BIOLOGICAL: CSL425

Sponsor

Seqirus